Form 483

BPI Labs, LLC Form 483, 2021-04-30

FDA issued a Form 483 to BPI Labs, LLC on 2021-04-30 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

BPI Labs, LLC · Largo, United States · Issued April 30, 2021

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 4 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Apr 2021
21 CFR 211.63

Equipment Design, Size and Location

Cited by Jessica L Pressley, Saundrea A Munroe, Emma R Schaefer, Jessica P Mcalister

30 Apr 2021
21 CFR 820.30(g)

Design Validation - Risk analysis not performed/inadequate

Cited by Jessica L Pressley, Saundrea A Munroe, Emma R Schaefer, Jessica P Mcalister

30 Apr 2021
21 CFR 820.30(h)

Design transfer - Lack of or inadequate procedures

Cited by Jessica L Pressley, Saundrea A Munroe, Emma R Schaefer, Jessica P Mcalister

30 Apr 2021
21 CFR 820.50(a)(1)

Evaluation and Selection, Suppliers, Contractors, etc.

Cited by Jessica L Pressley, Saundrea A Munroe, Emma R Schaefer, Jessica P Mcalister

30 Apr 2021
21 CFR 820.50(a)(2)

Supplier oversight

Cited by Jessica L Pressley, Saundrea A Munroe, Emma R Schaefer, Jessica P Mcalister

Inspected site

BLBPI Labs, LLCLargo, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.30(h)Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere